|
Species/ward type
|
n
|
% Susceptible
|
% MDR
|
|---|
|
C/T
|
P/T
|
FEP
|
CAZ
|
CRO
|
ATM
|
MEM
|
IMI
|
LVX
|
AMK
|
|---|
|
P. aeruginosad
|
|
ICU
|
495
|
96.0
|
72.3
|
78.0
|
76.6
|
NA
|
68.1
|
72.9
|
64.4
|
66.7
|
96.2
|
17.8
|
|
Non-ICU
|
583
|
96.7
|
79.4
|
83.0
|
82.9
|
NA
|
72.2
|
79.8
|
69.0
|
61.9
|
96.6
|
10.5
|
|
Enterobacteralese
|
|
ICU
|
1005
|
91.3
|
87.4
|
89.4
|
83.2
|
80.5
|
83.3
|
97.5
|
87.5
|
81.7
|
99.0
|
13.0
|
|
Non-ICU
|
726
|
92.6
|
89.3
|
89.4
|
83.3
|
79.6
|
85.1
|
98.5
|
85.1
|
83.0
|
98.6
|
11.7
|
|
P. aeruginosa + Enterobacterales
|
|
ICU
|
1500
|
92.9
|
82.4
|
85.6
|
81.0
|
NA
|
78.3
|
89.4
|
79.9
|
76.7
|
98.1
|
14.6
|
|
Non-ICU
|
1309
|
94.4
|
84.9
|
86.6
|
83.1
|
NA
|
79.4
|
90.1
|
77.9
|
73.6
|
97.7
|
11.2
|
- a Abbreviations: C/T, ceftolozane/tazobactam; P/T, piperacillin/tazobactam; FEP, cefepime; CAZ, ceftazidime; CRO, ceftriaxone; ATM, aztreonam; MEM, meropenem; IMI, impenem; LVX, levofloxacin; AMK, amikacin; NA, not available
- b Table does not show results for colistin because P. aeruginosa and Enterobacterales cannot be categorized as susceptible to colistin using CLSI M100 (2020) MIC breakpoint criteria
- c Statistically significant differences between ICU and non-ICU are shown in bold font
- d Of the 1237 isolates P. aeruginosa, 48 were from emergency rooms and 111 did not have a location provided and were excluded from this analysis
- e Of the 1938 isolates of Enterobacterales, 57 were from emergency rooms and 150 did not have a location provided and were excluded from this analysis
